Table 1.

 Demographics and baseline characteristics of study populations

	Semaglutide 1.0 mg n = 37	Placebo n = 38	Healthy n = 12
Age, years	56 (45–64)	57 (44–64)	43 (24–58)
HbA1c, %	7.3 (6.4–8.9)	7.3 (5.9–9.0)	N/A
HbA1c, mmol/l	56.1 (46.5–73.8)	55.7 (41.0–74.9)	N/A
Diabetes duration, years	8.3 (1.0–22.2)	8.7 (1.4–21.3)	N/A
Body weight, kg	93.2 (61.9–119.6)	90.0 (64.1–120.0)	81.9 (68.7–103.2)
BMI, kg/m2	29.5 (20.7–35.1)	29.7 (21.9–35.3)	26.8 (24.5–29.7)
Metformin use, n (%)	33 (89.1)	34 (89.5)	N/A
Male, n (%)	27 (73.0)	24 (63.2)	8 (66.7)

Data presented are mean (range) unless stated otherwise

N/A, not applicable